Mfg Part Number
Ab03901-10.3
Vector Labs Ab03901-10.3 Anti-CD155 [CD155.16 ], Human IgG1, Fc Silent™, kappa (100 μg)
Quick Overview
The original antibody was generated by immunizing KAC mice (KAC mouse is a genetically engineered mouse strain that expresses BAP -Biotin Accepting Peptide, sequence on constant part of kappa chain) subcutaneously with CD155-Fc fusion protein.
$570.70
Order will ship within 1-3 business days
| Product Class: | Purified |
|---|---|
| Clone ID: | CD155.16 |
| Heavy Chain Modification: | Fc Silent™ |
| Synonyms: | PVR; PVS; NECL-5; Poliovirus receptor; Nectin-like protein 5 |
| Amount: | 100 μg |
| Application Codes Clone: | FC |
| Shipping Temperature: | Wet Ice |
| Buffer Composition: | PBS with 0.02% Proclin 300. |
| Original Format: | IgG1 |
| Storage Temperature: | Store at 4⁰C for up to 3 months. For longer storage, aliquot and store at -20⁰C. |
| Chimeric Use Statement: | This chimeric human antibody was made using the variable domain sequences of the original Mouse IgG1 format, for improved compatibility with existing reagents, assays and techniques. |
| Specificity Statement: | This antibody binds human CD155 also called the poliovirus receptor (PVR). The binding of this antibody does not block binding of TIGIT to CD155/PVR. This protein mediates NK cell adhesion and triggers NK cell function. It also binds two NK cell receptors CD96 and CD226. CD155 is gaining more interest as a therapeutic target in the field of tumor immunology due to its prominent endogenous and immune functions. |
| Application Notes: | This antibody was used to identify CD155 expression on U-87 MG and U-87 MG PVRhi cell lines using flow cytometry. This antibody was used in the generation of anti-CD155 -saporin and anti-CD155-diphtheria immunotoxins and were tested for its antitumor activity. Cytotoxic effect was determined by ToxiLight kit. The results suggested that the immunotoxins were successful in killing CD155 expressing tumor cells.(WO2019102456). |
| Brand | Vector Labs |
|---|---|
| UNSPSC | 12161500 |